As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

"Ovarian cancer is what we call the silent killer because so many women are stage three or four by the time they get ...

The past 15 months have been challenging regarding treatment for my ovarian cancer. But today, my goal is to focus on healing ...

HAMPTON TOWNSHIP, Pa. (KDKA) -- The National Ovarian Cancer Coalition Great Lakes chapter held its biggest fundraiser of the ...

BLUE ASH, Ohio (WKRC) - An event this weekend in Blue Ash will help support cancer survivors. The Teal Power 5K Run and Walk to Fight Ovarian Cancer is Saturday. Everyone is invited to join hundreds ...